Marico's Q1 FY26 results, resurfacing an August move: revenue rose 23%, stake in Plix maker Satiya Nutraceuticals lifted to 60%

Resurfacing an August 2025 disclosure, Marico reported Q1 FY26 consolidated net profit of Rs 513 crore, up 8.2% year on year, as revenue from operations rose 23.3% to Rs 3,259 crore. India revenue grew 27.2%, while international revenue increased 12.9%. The company also raised its fully diluted stake in Plix maker Satiya Nutraceuticals to 60%.

— FiledWed, 23 Sept, 2026, 05:34 IST·First seen Wed, 23 Sept, 2026, 05:34 IST·Source Financial Express · BrandWagon

What happened

Marico posted Q1 FY26 profit growth of 8.2% and revenue growth of 23.3%, led by 27.2% India revenue growth. It raised its stake in Plix maker Satiya

Key facts

  • Q1 FY26 consolidated net profit: Rs 513 crore, up 8.2% YoY from Rs 474 crore
  • Revenue from operations: Rs 3,259 crore, up 23.31% YoY from Rs 2,643 crore
  • Total income: Rs 3,315 crore, including Rs 56 crore other income
  • India revenue: Rs 2,495 crore, up 27.17% YoY from Rs 1,962 crore
  • International revenue: Rs 764 crore, up 12.91% YoY from Rs 681 crore
  • India segment PBT: Rs 469 crore
  • International segment PBT: Rs 213 crore
  • Total expenses: Rs 2,659 crore, up from Rs 2,075 crore
  • Marico increased its Satiya Nutraceuticals stake to 60% on a fully diluted basis

Why this matters

By lifting its stake in Plix maker Satiya Nutraceuticals to 60%, Marico is deepening control of a high-growth nutrition platform and expanding beyond its core FMCG portfolio.

What to watch

  • Quarterly volume growth versus price-led growth in India.
  • Gross-margin movement and management commentary on copra, edible oil, crude derivatives and packaging costs.
  • Plix revenue growth, distribution expansion, EBITDA trajectory and any change in minority buyout plans.
  • Advertising-and-promotion spend as a percentage of sales.
  • International revenue recovery, particularly in Bangladesh, MENA and South Africa.
  • Rural demand trends, modern-trade growth and premium-category contribution.
  • Whether profit growth closes the gap with revenue growth in the next two quarters.
  • Expand Plix into Marico's general trade, modern trade and pharmacy distribution network while preserving its digital-native positioning.
  • Increase cross-selling and premium portfolio launches across nutrition, healthy foods, personal care and convenience-led wellness products.
  • Use strong India growth to raise advertising and promotional investment, especially in premium and urban categories.
  • Pursue selective bolt-on investments in health, nutrition and digital-first consumer brands rather than relying solely on core edible-oil and hair-care categories.
  • Calibrate pricing and pack-size actions to protect gross margins if commodity costs rise.